Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial (Q43918783)
Jump to navigation
Jump to search
scientific article published in March 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial |
scientific article published in March 2002 |
Statements
1 reference
Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial (English)
1 reference
1 reference
1 reference
Ruggero Ridolfi
1 reference
Vanna Chiarion-Sileni
1 reference
Michele Guida
1 reference
Antonella Romanini
1 reference
Andrea Freschi
1 reference
Rolando Nortilli
1 reference
Sonia Brugnara
1 reference
Patrizia Vitali
1 reference
Italian Melanoma Intergroup
1 reference
1 March 2002
1 reference
1 reference
20
1 reference
6
1 reference
1600-1607
1 reference